Mark Antonios

Q: What is Mark Antonios email address?

Email Mark Antonios at markooka88@gmail.com and mark.antonios@bms.com. This email is the most updated Mark Antonios email found in 2026.

Q: How to contact Mark Antonios?

To contact Mark Antonios send an email to markooka88@gmail.com or mark.antonios@bms.com. If you want to call Mark Antonios try calling on +17326140746.

Director Cardiovascular Congress Excellence Strategy Lead at Bristol Myers Squibb | New York City Metropolitan Area

About Mark Antonios

Mark Antonios serves as the Director of Portfolio Congress Strategy and Medical Capabilities at Bristol Myers Squibb, where he leverages his extensive background as an experienced pharmacist to drive impactful medical congress initiatives. With a proven track record in both the pharmaceutical industry and hospital settings, Mark excels at navigating complex challenges and crafting innovative solutions that resonate with healthcare professionals and stakeholders alike. His leadership of a dedicated team of six has been pivotal in ensuring a cohesive and strategic presence at medical congresses, where he meticulously plans and executes pre-, peri-, and post-congress activities that align with the company’s broader business priorities.

Mark’s expertise spans a variety of critical areas, including clinical research, medication therapy management, and patient safety, allowing him to bridge the gap between scientific rigor and business acumen effectively. His ability to build strong relationships with both internal teams and external partners has been instrumental in fostering collaboration and driving initiatives that enhance the overall congress experience. By integrating insights from managed care and inpatient settings, Mark ensures that Bristol Myers Squibb’s congress strategies not only meet regulatory standards but also address the evolving needs of healthcare providers and patients.

In his role, Mark is committed to enhancing the visibility and impact of the company’s portfolio, ensuring that key therapeutic areas are represented effectively at major medical events. His strategic vision and operational expertise position him as a key player in advancing the company’s mission to deliver innovative therapies that improve patient outcomes. Through his leadership, Mark continues to shape the future of medical congress engagement within the pharmaceutical landscape.

Mark Antonios Work